Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2458 to 2507 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2458\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 13, member 2 (renal sodium/dicarboxylate cotransporter) (na(+)/dicarboxylate cotransporter 1) (nadc-1). [source:swissprot;acc:q13183]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
204.683\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.326\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00314\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2459\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidate cytidylyltransferase 1 (ec 2.7.7.41) (cdp-diglyceride synthetase 1) (cdp-diglyceride pyrophosphorylase 1) (cdp- diacylglycerol synthase 1) (cds 1) (ctp:phosphatidate cytidylyltransferase 1) (cdp-dag synthase 1) (cdp-dg synthetase 1). [source:swissprot;acc:q92903]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
204.653\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.286\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00309\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2460\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pepsin a precursor (ec 3.4.23.1). [source:swissprot;acc:p00790]\vspace{3pt}}&\multirow{12}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
235.812\vspace{3pt}}}&\multirow{12}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
235.088\vspace{3pt}}}&\multirow{12}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00308\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2461\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 20 (phosphate transporter), member 2; glvr-2; pit-2; gibbon ape leukemia virus receptor 2; murine leukemia virus, amphotropic; receptor. [source:refseq;acc:nm\_006749]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2462\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
farnesyl pyrophosphate synthetase (fpp synthetase) (fps) (farnesyl diphosphate synthetase) [includes: dimethylallyltransferase (ec 2.5.1.1); geranyltranstransferase (ec 2.5.1.10)]. [source:swissprot;acc:p14324]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2463\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protocadherin 15 precursor. [source:swissprot;acc:q96qu1]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2464\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 20 (phosphate transporter), member 1; glvr-1; pit-1; gibbon ape leukemia virus receptor 1. [source:refseq;acc:nm\_005415]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2465\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lipocalin-interacting membrane receptor. [source:refseq;acc:nm\_018113]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2466\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein gli1 (glioma-associated oncogene) (oncogene gli). [source:swissprot;acc:p08151]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2467\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
suppressor of fused. [source:refseq;acc:nm\_016169]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2468\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein gli3. [source:swissprot;acc:p10071]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2469\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
limb region 1 protein; limb region 1. [source:refseq;acc:nm\_022458]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2470\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gastricsin precursor (ec 3.4.23.3) (pepsinogen c). [source:swissprot;acc:p20142]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2471\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein gli2 (tax helper protein). [source:swissprot;acc:p10070]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2472\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tumor endothelial marker 6; thyroid specific ptb domain protein; tensin 3. [source:refseq;acc:nm\_022748]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.218\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.564\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00301\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2473\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
c-jun-amino-terminal kinase interacting protein 3 (jnk-interacting protein 3) (jip-3) (jnk map kinase scaffold protein 3) (mitogen- activated protein kinase 8-interacting protein 3). [source:swissprot;acc:q9upt6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.644\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.991\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.003\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2474\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s protease regulatory subunit 6a (tat-binding protein 1) (tbp-1) (proteasome subunit p50). [source:swissprot;acc:p17980]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.285\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00298\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2475\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
c1 domain-containing phosphatase and tensin-like protein isoform 2; putative protein tyrosine phosphatase; c1 domain-containing phosphatase and tensin-like protein; tensin 2. [source:refseq;acc:nm\_015319]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.219\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.571\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2476\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
xylulokinase homolog; xylulokinase (h. influenzae) homolog. [source:refseq;acc:nm\_005108]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
211.205\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.577\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2477\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l30 isoform a. [source:refseq;acc:nm\_145212]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
216.177\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
216.801\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00289\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2478\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s protease regulatory subunit s10b (proteasome subunit p42) (p44) (conserved atpase domain protein 44) (cadp44). [source:swissprot;acc:q92524]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2479\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rho-gtpase-activating protein 8. [source:swissprot;acc:q9nsg0]\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
218.093\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
218.72\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00287\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2480\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rho-gtpase-activating protein 1 (gtpase-activating protein rhoogap) (rho-related small gtpase protein activator) (cdc42 gtpase-activating protein) (p50-rhogap). [source:swissprot;acc:q07960]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2481\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin light chain 2 (klc 2). [source:swissprot;acc:q9h0b6]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2482\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin heavy chain (ubiquitous kinesin heavy chain) (ukhc). [source:swissprot;acc:p33176]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2483\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin heavy chain isoform 5c (kinesin heavy chain neuron-specific 2). [source:swissprot;acc:o60282]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2484\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal kinesin heavy chain (nkhc) (kinesin heavy chain isoform 5a) (kinesin heavy chain neuron-specific 1). [source:swissprot;acc:q12840]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2485\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin light chain 1 (klc 1). [source:swissprot;acc:q07866]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2486\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor iiia (factor a) (tfiiia). [source:swissprot;acc:q92664]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2487\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
exocyst complex component sec3 (bm-012). [source:swissprot;acc:q9nv70]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2488\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatitis c virus core-binding protein 6; cervical cancer oncogene 3. [source:refseq;acc:nm\_023934]\vspace{3pt}}&\multirow{11}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
194.527\vspace{3pt}}}&\multirow{11}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
195.08\vspace{3pt}}}&\multirow{11}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00284\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2489\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dc11 protein. [source:refseq;acc:nm\_020186]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2490\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
amyloid beta precursor protein-binding protein 1; amyloid protein-binding protein 1. [source:refseq;acc:nm\_003905]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2491\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
5-aminolevulinic acid synthase, erythroid-specific, mitochondrial precursor (ec 2.3.1.37) (delta-aminolevulinate synthase) (delta-ala synthetase) (alas-e). [source:swissprot;acc:p22557]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2492\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-activating enzyme e1c (uba3 homolog, yeast); ubiquitin-activating enzyme e1c (homologous to yeast uba3). [source:refseq;acc:nm\_003968]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2493\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-activating enzyme e1 (a1s9 protein). [source:swissprot;acc:p22314]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2494\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcium-binding mitochondrial carrier protein aralar1 (solute carrier family 25, member 12). [source:swissprot;acc:o75746]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2495\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma antigen recognized by t cells 2. [source:refseq;acc:nm\_018194]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2496\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
5-aminolevulinic acid synthase, nonspecific, mitochondrial precursor (ec 2.3.1.37) (delta-aminolevulinate synthase) (delta-ala synthetase) (alas-h). [source:swissprot;acc:p13196]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2497\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcium-binding mitochondrial carrier protein aralar2 (solute carrier family 25, member 13) (citrin). [source:swissprot;acc:q9ujs0]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2498\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
acyl carrier protein, mitochondrial precursor (acp) (nadh-ubiquinone oxidoreductase 9.6 kda subunit) (ci-sdap). [source:swissprot;acc:o14561]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2499\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nin one binding protein; adenocarcinoma antigen recognized by t lymphocytes 4. [source:refseq;acc:nm\_014062]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
231.414\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
230.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00283\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2500\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
baculoviral iap repeat-containing protein 5 (apoptosis inhibitor survivin) (apoptosis inhibitor 4). [source:swissprot;acc:o15392]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.949\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.552\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00275\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2501\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase c binding protein 1 (rack7) (cutaneous t-cell lymphoma associated antigen se14-3) (ctcl tumor antigen se14-3) (zinc finger mynd domain containing protein 8). [source:swissprot;acc:q9ulu4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.398\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.809\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00272\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2502\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenovirus 5 e1a-binding protein (bs69 protein). [source:swissprot;acc:q15326]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.417\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.844\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00264\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2503\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s protease regulatory subunit 4 (p26s4). [source:swissprot;acc:q03527]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.581\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.137\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00258\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2504\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tensin. [source:refseq;acc:nm\_022648]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.238\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.682\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00255\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2505\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromobox protein homolog 5 (heterochromatin protein 1 homolog alpha) (hp1 alpha) (antigen p25). [source:swissprot;acc:p45973]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
187.853\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
188.326\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00252\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2506\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
44050 protein. [source:refseq;acc:nm\_178832]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
151.386\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
151.009\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0025\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2507\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear inhibitor of protein phosphatase-1 (nipp-1) (protein phosphatase 1, regulatory inhibitor subunit 8) [includes: activator of rna decay (ec 3.1.4.-) (ard-1)]. [source:swissprot;acc:q12972]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/